This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Behrens S, Häfner H, De Vry J, Gattaz WF (1992) Estradiol attenuates dopamine-medicated behavior in rats. Implications for sex differences in schizophrenia. Schizophr Res 6: 114
Brambilla F, Penati G (1978) Perspectives in endocrine psychobiology. In: Brambilla F and Bridges P (ed). Perspectives in endocrine psychobiology. Witey, London, 309–422
DiPaolo T, Payet P, Labrie F (1982) Effect of prolactin and estradiol on rat striated dopamine receptors. Life Sci 31: 2921–2929
Ferretti C, Blengio M, Vigna I, Ghia P, Gerazzani E (1992) Effects of estradiol on the ontogenesis of striatial dopamine D1 and D2 receptor sites in male and female rats. Brain Res 571: 212–217
Fink G (1995) The psychoprotective action of estrogen is mediated by central serotonergic as well as dopaminergic mechanisms. In: Takada A and Curzon G (eds). Serotonin in the central nervous system and periphery. Elsevier Science, Amsterdam, 175–187
Fink G, Sumner B, McQueen JK, Wilson H, Rose R (1998) Sex steriod control of mood, mental state and memory. Clin Exp Pharmacol Physiol 25: 764–765
Fink G, Sumner B, Rosie R, Wilson H, McQueen J (1999) Androgen actions on central serotonin neurotransmission: relevance for mood, mental state and memory. Behav Brain Res 105: 53–68
Gordon HH, Borison RL, Diamond BI (1980) Modulation of dopamine receptor sensitivity by estrogen. Biol Psychiatry 15: 389–396
Gordon JH, Perry KO (1983) Pre-and postsynaptic neurochemical alteration following estrogen-induced striatal dopamine hypo-and hypersensitivity. Brain Res Bull 10: 425–428
Häfner H (1991) The epidemiology of beginning schizophrenia. Presented at the WPA Section of Epidemiology and Community Psychiatry Symposium, June 14–16, Oslo
Hoskins RG (1920) Endocrine factors in dementia praecox. N Engl J Med 200: 361
Joyce JN, Smith RL, Van Hartesveldt C (1982) Estradiol suppresses then enhances intracaudate dopamine-induced contralateral deviation. Eur J Pharm 81: 117–122
Kraepelin E (1982) Psychiatrie, vol 3, part 2, 8th ed. Translated (1919). Dementia praecox and paraphrenia. Livingstone, Edinburgh
Kulkarni J, de Castella A, Riedel A, Taffe J, Fitzgerald P, Burger H (2001) Estrogen — a potential new treatment in schizophrenia. Schizophr Res 48: 137–144
Kulkarni J, Smith D, McKenzie D, Hill C, Keks N, Singh B, Copolov D (1995) Donadotrophin response to naloxone challenge in female and male psychotic patients. Biol Psychiatry 38: 701–703
Kulkarni J, de Castella A, Smith D, Taffe J, Keks N, Copolov D (1996a) A clinical trial of the effects of estrogen in acutely psychotic women. Schizoph Res 20: 247–252
Kulkarni J, Gostt K, de Castella A (1996b) The menstrual cycle in women with schizophrenia. Schizophr Res 18: 254
Mason JW (1975) Emotion as reflected in patterns of endocrine investigation. In: Levi L (ed) Emotions: their parameters and measurement. Raven Press, New York, 143–181
Mosselman S, Polman J, Dukema R (1996) ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett 392: 49–53
Perry KO, Diamond BI, Fields JZ, Gordon JH (1981) Hypophysectomy induced hyper-sensitivity to dopamine: antagonism by estrogen. Brain Res 226: 211–219
Sachar EJ, Mason JW, Kolmer HS, Arfess KL(1963) Psychoendocrine aspects of acute schizophrenic reactions. Psychosom Med 25: 510
Seeman MV, Lang M (1990) The role of estrogens in schizophrenia gender differences. Schizophr Bull 16: 185–195
Shughrue PJ, Lane MV, Merchenthaler I (1997) Comparative distribution of estrogen receptor and X and B MRNA in the rat central nervous system. J Compr Neurol 388: 507–525
Sumner BEH, Grant DE, Rosie R, Hegele-Hartung Ch, Fritzemeier KH, Fink G (1999) Effects of tamoxifen on serotonin transporter and 5-hydroxytryptamine 2A receptor binding sites and mRNA levels in the brain of ovariectomized rats with or without acute estradiol replacement. Mol Brain Res 73: 119–128
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag/Wien
About this chapter
Cite this chapter
Kulkarni, J. (2005). Clinical Estrogen Trials in Patients with Schizophrenia. In: Bergemann, N., Riecher-Rössler, A. (eds) Estrogen Effects in Psychiatric Disorders. Springer, Vienna. https://doi.org/10.1007/3-211-27063-9_5
Download citation
DOI: https://doi.org/10.1007/3-211-27063-9_5
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-40485-0
Online ISBN: 978-3-211-27063-9
eBook Packages: MedicineMedicine (R0)